Covid: India’s First Omicron-Specific Booster Vaccine Gets Drug Controller Nod
[ad_1] The Drug Control General of India (DCGI) has granted emergency use authorisation (EUA) to an Omicron-specific booster vaccine developed by Gennova Biopharmaceuticals Ltd. The vaccine has been developed by Gennova Biopharmaceuticals in collaboration with the Department of Biotechnology (DBT) under the ‘Mission COVID Suraksha’. The mRNA-based vaccine, GEMCOVAC-OM, was developed using the indigenous platform … Read more